rs121908431
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_014112.5(TRPS1):c.1870C>T(p.Arg624*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014112.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPS1 | NM_014112.5 | c.1870C>T | p.Arg624* | stop_gained | Exon 4 of 7 | ENST00000395715.8 | NP_054831.2 | |
TRPS1 | NM_001282903.3 | c.1849C>T | p.Arg617* | stop_gained | Exon 4 of 7 | NP_001269832.1 | ||
TRPS1 | NM_001282902.3 | c.1843C>T | p.Arg615* | stop_gained | Exon 3 of 6 | NP_001269831.1 | ||
TRPS1 | NM_001330599.2 | c.1831C>T | p.Arg611* | stop_gained | Exon 3 of 6 | NP_001317528.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Trichorhinophalangeal dysplasia type I Pathogenic:1Other:1
- -
- -
Inborn genetic diseases Pathogenic:1
The c.1870C>T (p.R624*) alteration, located in exon 4 (coding exon 3) of the TRPS1 gene, consists of a C to T substitution at nucleotide position 1870. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 624. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This mutation (also designated as p.R611* in the literature) has been identified in several individuals with trichorhinophalangeal syndrome and segregated with disease in one family (Momeni, 2000; Maas, 2015). In another family, the proband presented with brachydactyly, short stature, bulbous nose, long flat philtrum, and thin upper lip; her sister with similar skeletal issues and brachydactyly as well as her mother with brachydactyly were also heterozygous for this variant (Karaca, 2019). Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also known as R611X and R615X; This variant is associated with the following publications: (PMID: 25525159, 25792522, 10615131, 30914275, 32347565, 15616909) -
Trichorhinophalangeal dysplasia type I;C1860823:Trichorhinophalangeal syndrome, type III Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg624*) in the TRPS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRPS1 are known to be pathogenic (PMID: 11112658). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with clinical features of trichorhinophalangeal syndrome (PMID: 10615131, 30914275). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5570). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at